DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages

Breast cancer (BC) is the second leading cause of cancer deaths among women. DEK is a known oncoprotein that is highly expressed in over 60% of breast cancers and is an independent marker of poor prognosis. However, the molecular mechanisms by which DEK promotes tumor progression are poorly understo...

Full description

Bibliographic Details
Main Authors: Nicholas A. Pease, Miranda S. Shephard, Mathieu Sertorio, Susan E. Waltz, Lisa M. Privette Vinnedge
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
DEK
Online Access:https://www.mdpi.com/2072-6694/12/7/1936